What are the proposed mechanisms by which biologic therapies could potentially lead to posterior reversible encephalopathy syndrome (PRES)?
Abstract
Biologic therapies are thought to lead to PRES through endothelial dysfunction, BBB disruption, and inflammatory responses. These speculative mechanisms require further research for confirmation.
Fields of Study & Subjects
Neurological Complications and Syndromes
Cerebral Venous Sinus Thrombosis
Vasculitis and related conditions
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 January 2026